"Medicare Part D" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A stand-alone drug plan offered by insurers and other private companies to beneficiaries that receive their Medicare Part A and/or B benefits through the Original Medicare Plan. It includes Medicare Private Fee-for-Service Plans that do not offer prescription drug coverage and Medicare Cost Plans offering Medicare prescription drug coverage. The plan was enacted as the Medicare Prescription Drug, Improvement and Modernization Act of 2003 with coverage beginning January 1, 2006.
| Descriptor ID |
D054524
|
| MeSH Number(s) |
N03.219.521.576.343.575.500 N03.219.521.576.343.840.938 N03.706.615.752
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Medicare Part D".
Below are MeSH descriptors whose meaning is more specific than "Medicare Part D".
This graph shows the total number of publications written about "Medicare Part D" by people in this website by year, and whether "Medicare Part D" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 3 | 3 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Medicare Part D" by people in Profiles.
-
Evaluating perceptions of social determinants of health and Part D star performance of Medicare Advantage-contracted primary care providers serving a South Texas market. J Manag Care Spec Pharm. 2021 May; 27(5):544-553.
-
Evaluating Success Factors of a Medication Adherence Tracker Pilot Program in Improving Part D Medication Adherence Metrics in a Medicare Advantage Plan: Importance of Provider Engagement. J Manag Care Spec Pharm. 2020 May; 26(5):662-667.
-
Factors Associated with Entering the Prescription Drug Coverage Gap Among Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease. Popul Health Manag. 2021 04; 24(2):241-248.
-
Antihypertensive adherence and outcomes among community-dwelling Medicare beneficiaries: the Atherosclerosis Risk in Communities Study. J Eval Clin Pract. 2018 02; 24(1):48-55.
-
Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis. J Nephrol. 2017 Apr; 30(2):281-288.
-
Physician Perception of Patient Medication Adherence in a Cohort of Medicare Advantage Plans in Texas. J Manag Care Spec Pharm. 2016 Mar; 22(3):305-12.
-
Comparative Cognitive Profile of Second-Generation Antidepressants in Elderly Nursing Home Residents With Depression. Ann Pharmacother. 2016 Feb; 50(2):96-105.
-
Thienopyridine use after coronary stenting in low income patients enrolled in medicare part D receiving maintenance dialysis. J Am Heart Assoc. 2014 Oct 21; 3(5):e001356.
-
VHA pharmacy use in veterans with Medicare drug coverage. Am J Manag Care. 2009 Mar 16; 15(3):e1-8.
-
The impact of Medicare Part D on psychotropic utilization and financial burden for community-based seniors. Psychiatr Serv. 2008 Oct; 59(10):1191-7.